clinical trial · NCT01838512
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
Bristol-Myers Squibb·—·active not recruiting·n = 2,555
Multiple Myeloma
brief summary
The purpose of this study is to assess the clinical effectiveness of all approved multiple myeloma (MM) therapies in the newly-diagnosed (NDMM) and the relapsed/refractory MM (RRMM) settings in real-world clinical practice.
started
Jun 13, 2012
primary completion
Mar 31, 2030
completion
Mar 31, 2030
last updated
Dec 2, 2025
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol